Metadate CD Related Published Studies
Well-designed clinical trials related to Metadate CD (Methylphenidate)
Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. [2009.08]
Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. [2009.07]
Behavioral response to methylphenidate challenge: influence of early life parental care. [2009.07]
Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient rehabilitation. [2009.06]
Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder. [2009.06]
Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder. [2009.06]
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. [2009.06]
Predicting Methylphenidate Response in Long-Term Survivors of Childhood Cancer: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. [2009.05.22]
The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial. [2009.05.15]
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. [2009.05]
Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). [2009.05]
Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. [2009.05]
Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder. [2009.04.01]
Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder. [2009.04.01]
Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths. [2009.04]
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. [2009.03]
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. [2009.03]
A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. [2009.03]
Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease. [2009.03]
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. [2009.03]
Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. [2009.01.15]
Association Between Homozygosity of a G Allele of the Alpha-2a-Adrenergic Receptor Gene and Methylphenidate Response in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. [2009.01.14]
Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). [2009.01]
Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder. [2009.01]
Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: A randomized, crossover, double-blind, placebo controlled inpatient trial. [2008.12.05]
Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting. [2008.12]
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. [2008.12]
A pharmacokinetic study of two modified-release methylphenidate formulations under different food conditions in healthy volunteers. [2008.09]
Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. [2008.09]
Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. [2008.08]
[Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children] [2008.08]
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. [2008.06]
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. [2008.06]
A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. [2008.06]
Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study. [2008.06]
A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. [2008.05.15]
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. [2008.05]
Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. [2008.05]
Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. [2008.05]
Can methylphenidate reduce fall risk in community-living older adults? A double-blind, single-dose cross-over study. [2008.04]
Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. [2008.04]
Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). [2008.03.05]
Anxiety, methylphenidate response, and working memory in children with ADHD. [2008.03]
A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. [2008.03]
[Methylphenidate in palliative care in cancer patient: a double-blind randomised trial versus placebo] [2008.02]
The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder. [2008.02]
Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder. [2008.02]
Rebound Effects with Long-Acting Amphetamine or Methylphenidate Stimulant Medication Preparations among Adolescent Male Drivers with Attention-Deficit/Hyperactivity Disorder. [2008.02]
Methylphenidate hydrochloride increases energy expenditure in healthy adults. [2008.02]
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. [2008.02]
A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder. [2008.01.17]
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. [2008.01]
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. [2008.01]
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. [2008.01]
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder : rapid onset of effect. [2008]
Anxiety, Methylphenidate Response, and Working Memory in Children With ADHD. [2007.12.19]
A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. [2007.12.01]
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. [2007.12]
Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. [2007.12]
The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. [2007.11.01]
Comorbidity Moderates Response to Methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). [2007.11]
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. [2007.11]
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. [2007.10.31]
Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. [2007.10]
Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. [2007.10]
Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. [2007.10]
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). [2007.10]
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). [2007.10]
Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. [2007.10]
The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder. [2007.10]
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. [2007.09.14]
A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-threo-methylphenidate HCl in Brain Tumor Patients Receiving Radiation Therapy. [2007.09.13]
Effects of methylphenidate on working memory components: influence of measurement. [2007.09]
Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. [2007.09]
Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial. [2007.08.02]
Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food? [2007.08]
Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers. [2007.07]
Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder. [2007.07]
Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. [2007.06.15]
Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. [2007.06]
Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. [2007.06]
The Neuropsychological Effects of Chronic Methylphenidate on Drug-Naive Boys with Attention-Deficit/Hyperactivity Disorder. [2007.05.31]
Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. [2007.04.01]
An integrative approach to determine the best behavioral and biological markers of methylphenidate. [2007.03]
Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. [2007.03]
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. [2007.03]
Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. [2007.02]
Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form. [2007.01]
The effects of methylphenidate on the classroom behavior of elementary school-age children with cerebral palsy: a preliminary observational analysis. [2007.01]
Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. [2006.12]
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. [2006.12]
Methylphenidate modulates cerebral post-stroke reorganization. [2006.11.15]
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. [2006.11]
Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. [2006.11]
Safety and tolerability of methylphenidate in preschool children with ADHD. [2006.11]
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. [2006.09]
Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. [2006.09]
An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. [2006.08]
Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens. [2006.08]
[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD] [2006.07]
|
